Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TARRYTOWN, N.Y., May 01, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new and updated data from its oncology and hematology portfolio will be shared at the...
-
Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
-
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for...
-
MILWAUKEE, May 01, 2025 (GLOBE NEWSWIRE) -- LeaseCrunch LLC, a leading provider of software solutions that empower CPA firms and their clients, today announced its participation in a series of...
-
MELVILLE, N.Y., May 01, 2025 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a leading provider of multi-cloud hosting, managed cloud services, disaster...
-
PALO ALTO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and...
-
COLUMBIA, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Tenable®, the exposure management company, today announced its co-chief executive officers, Steve Vintz and Mark Thurmond, will attend the J.P. Morgan...
-
Groundbreaking sessions explore the U.S. Department of Veterans Affairs (VA)’s role in psychedelic research, Veteran-led advocacy, and community-driven healing modelsSpeakers include Psychedelics...
-
MONTREAL, May 01, 2025 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) will issue its first-quarter 2025 financial and operating results after the market close. CN's senior officers will review the...
-
PRINCETON, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs...